Details of the Drug Combinations

General Information of This Drug (ID: DMEVAOB)

Drug Name

Gemcabene DMEVAOB

Synonyms

183293-82-5; UNII-B96UX1DDKS; B96UX1DDKS; 6-(5-Carboxy-5-methyl-hexyloxy)-2,2-dimethyl-hexanoic acid; Gemcabene [INN]; PD-72953; PD 72953; AC1L4IHZ; SCHEMBL761631; CHEMBL2110686; CTK4D8457; DTXSID60171407; SDMBRCRVFFHJKR-UHFFFAOYSA-N; ZINC1893031; PD72953; DB05123; ACM183293825; 6,6'-Oxybis(2,2-dimethylhexanoic acid); Hexanoic acid,6,6'-oxybis[2,2-dimethyl-; FT-0743032; 2,2,2',2'-Tetramethyl-6,6'-oxydihexanoic acid; 6-(6-hydroxy-5,5-dimethyl-6-oxohexoxy)-2,2-dimethylhexanoic acid; 6-(5-CARBOXY-5-METHYL-HEXOXY)-2,2-DIME

Indication

Disease Entry	ICD 11	Status	REF
Hypertriglyceridemia	5C80.1	Phase 2	[1]
------------------------------------------------------------------------------------

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

2 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Atorvastatin + Gemcabene	DCGXBJT	Atorvastatin	Hypercholesteremia	[2]
Simvastatin + Gemcabene	DCIMXJL	Simvastatin	Hypercholesterolemia	[3]
------------------------------------------------------------------------------------

References

1	Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2	ClinicalTrials.gov (NCT02587416) Effect of Gemcabene on the Pharmacokinetics of Atorvastatin in Healthy Volunteers
3	ClinicalTrials.gov (NCT02587390) Effect of Gemcabene on the Pharmacokinetics of Simvastatin in Healthy Volunteers